51³Ô¹ÏÍø
Tag - daiichi-sankyo
Subscribe
Digital
Print
July 24, 2026
Subscribe
Digital
Print
Heat
Parliament
China
Latest News
Home Delivery
51³Ô¹ÏÍø
Politics
Society
Crime & Legal
Science & Health
Explainer
History
WORLD
Politics
Crime & Legal
Science & Health
Society
ASIA PACIFIC
Politics
Crime & Legal
Science & Health
Society
BUSINESS
Companies
Economy
Markets
Tech
SPORTS
Sumo
Soccer
Baseball
Basketball
Tennis
Olympics
More sports
OPINION
Editorials
Commentary
Geoeconomic Briefing
Environment
CLIMATE CHANGE
Energy
SUSTAINABILITY
WILDLIFE
EARTH SCIENCE
LIFE
Travel
Digital
Food & Drink
Style & Design
Language
Lifestyle
CULTURE
Film
Books
Music
Art
TV & Streaming
Stage
Entertainment news
COMMUNITY
Voices
Issues
How-tos
Our Lives
My Account
My Bookmarks
Logout
Subscribe for more access
DAIICHI SANKYO
BUSINESS
/
Companies
May 12, 2026
Daiichi Sankyo bets on new cancer drugs to fuel future growth
The Japanese drugmaker aims to more than double oncology revenue to above ?2.3 trillion by 2030 and become one of the world¡¯s top five oncology players by 2035.
51³Ô¹ÏÍø
/
Science & Health
Mar 3, 2026
Japan expert panel OKs Daiichi Sankyo¡¯s MMR vaccine
If approved by the minister, the vaccine, primarily for children, will be the sole MMR vaccine available in Japan.
51³Ô¹ÏÍø
/
Science & Health
Dec 18, 2025
Japan to start OTC sales of emergency contraception in February
Daiichi Sankyo¡¯s drug, Norlevo, will mark the first time such a pill will be available without a prescription in Japan.
BUSINESS
/
Companies
Oct 7, 2025
Breast cancer patients lived longer on drug Datroway, says maker
The drug is said to have significantly improved survival and delayed disease progression in patients with a particularly hard to treat form of the disease.
BUSINESS
Jan 31, 2025
AstraZeneca and Daiichi¡¯s breast cancer drug gets EU backing
The green light from the European Medicines Agency is the first backing in the EU for the medicine, following its approval in the U.S. and Japan.
BUSINESS
/
Companies
Jan 20, 2025
Daiichi Sankyo rises most in five months on cancer drug approval
Datroway, developed with AstraZeneca, has been approved for patients with advanced breast tumors.
BUSINESS
Jan 18, 2025
AstraZeneca and Daiichi Sankyo win U.S. approval for breast cancer drug
The Food and Drug Administration approved the drug for patients with advanced breast tumors whose cells bear a certain genetic signature.
51³Ô¹ÏÍø
/
Crime & Legal
Oct 31, 2024
Ex-employee of drugmaker sentenced to 16 years for methanol murder
Tokyo District Court on Wednesday sentenced a former employee of drugmaker Daiichi Sankyo to 16 years in prison for the murder of his wife by methanol poisoning in 2022.
51³Ô¹ÏÍø
/
Crime & Legal
Oct 11, 2024
Ex-Daiichi Sankyo employee faces 18 years for allegedly poisoning wife
The indictment states that Keisuke Yoshida intentionally poisoned his 40-year-old wife, Yoko, by having her ingest methanol at their home in Tokyo.
BUSINESS
/
Companies
Oct 11, 2024
Daiichi Sankyo eyes newer cancer drugs to stave off rivals
The Japanese drugmaker has emerged as a leader in ADC, a type of cancer therapy that targets cancerous cells while sparing the healthy ones.
51³Ô¹ÏÍø
/
Science & Health
Sep 17, 2024
Daiichi wants to go it alone in search for targeted cancer drugs
Investors are betting on Daiichi¡¯s continued success, with its share price up 122% in the last five years.
51³Ô¹ÏÍø
/
Crime & Legal
Sep 2, 2024
Ex-employee of Daiichi Sankyo denies poisoning his wife with methanol
Keisuke Yoshida, formerly a senior researcher at the pharmaceutical firm, said he had never thought of killing his wife.
51³Ô¹ÏÍø
/
Science & Health
Aug 14, 2024
Health Minister Keizo Takemi on how to improve Japan¡¯s health care system
Digitalization, hiring high-skilled foreign workers and increasing wages are among the steps that Japan could take.
51³Ô¹ÏÍø
/
Science & Health
Aug 14, 2024
Global mindset crucial for reform of Japan¡¯s health care, minister says
International strategies and domestic health care reform are inextricably linked, says health minister Keizo Takemi.
51³Ô¹ÏÍø
/
Science & Health
Nov 28, 2023
Japan approves first domestically developed COVID-19 XBB vaccine
The XBB-adapted coronavirus vaccine will be available as a booster under the nation¡¯s free COVID-19 vaccination program beginning next week.
BUSINESS
Oct 20, 2023
Merck signs $5.5 billion deal with Daiichi for cancer therapy development
Daiichi Sankyo is aiming for at least ?900 billion of revenue from its oncology business in the fiscal year ending in March 2026.
51³Ô¹ÏÍø
/
Science & Health
Aug 1, 2023
Japan panel endorses first domestically developed COVID vaccine
The shot is based on the original strain of the coronavirus, making it unlikely that it will be used in Japan or elsewhere.
BUSINESS
/
Companies
Jun 7, 2023
AstraZeneca¡¯s Japan partner to go solo on future cancer drugs
Daiichi Sankyo is expanding its sales and development staff overseas, aiming to boost production capacity so that it can handle its cancer drugs business entirely on its own.
BUSINESS
Jan 13, 2023
Japan¡¯s Daiichi Sankyo applies for approval of mRNA COVID vaccine
An approval would give Japan a homegrown mRNA vaccine ¡ª a vaccine type that has played a dominant role in the country¡¯s COVID-19 inoculation drive to this point.
51³Ô¹ÏÍø
/
Science & Health
Nov 15, 2022
Japan¡¯s Daiichi Sankyo says mRNA COVID vaccine successful in booster trial
Approval would give Japan a home-grown source for mRNA vaccines, which have made up the bulk of its COVID-19 inoculations to date.
? Prev
1
2
Next ?
WHAT¡¯S TRENDING
Editors' Picks
Japan scientists identify clusters of protein believed to trigger Alzheimer¡¯s disease
Indian brothers make manga debut in Japan
Japan weighs regulating Pokemon cards amid trading mania
Low-income families in Japan cut food and air conditioning during summer break
Iran strikes on CIA facilities prompt questions about possible Russian role
The sci-fi sensibilities of electronic trio Black Boboi
A perfect storm: Kaze Fujii fans flock to Fuji Rock
Can Japanese comedy get laughs in English? Yoshimoto Kogyo lets the jokes rip
The 180-day locals: Life on Japan¡¯s digital nomad visa
Japan reveals hint of new defense spending target in fiscal blueprint
Podcast
Kabukicho: Tokyo¡¯s ¡®stadium of desire¡¯
Longform
Why Japan¡¯s utility poles won¡¯t be disappearing anytime soon
By
Alex K.T. Martin
SUSTAINABLE 51³Ô¹ÏÍø
SPECIAL SUPPLEMENTS
Sponsored contents planned and edited by JT Media Enterprise Division.
SUPPLEMENTS BINDER